[go: up one dir, main page]

TIMoTHY et al. - Google Patents

Receptor Function'

TIMoTHY et al.

View PDF
Document ID
3322574386510357308
Author
TIMoTHY A
DAvooN D
Ho M
KÜRzINGER K
MART E
SANCHEz-MADRID F

External Links

Snippet

Killer cells are an important component in the immune response to cells with altered or foreign cell surface antigens. Antigen-specific killing is mediated by a subset of Thy-1" thymus-derived (T) lymphocytes which have been termed cytolytic T lymphocytes (CTL). CTL …
Continue reading at projects.iq.harvard.edu (PDF) (other versions)

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/70539—MHC-molecules, e.g. HLA-molecules
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/73—Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
    • A61K47/48—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates
    • A61K47/48369—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the modifying part being an antibody, an immunoglobulin, or a fragment thereof, e.g. a Fc-fragment
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/30—Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto

Similar Documents

Publication Publication Date Title
US8110189B2 (en) T cell inhibitory receptor compositions and uses thereof
EP0326595B1 (en) Peptides and antibodies that inhibit platelet adhesion
Sanchez-Madrid et al. Mapping of antigenic and functional epitopes on the alpha-and beta-subunits of two related mouse glycoproteins involved in cell interactions, LFA-1 and Mac-1.
US6033876A (en) Anti-CD30 antibodies preventing proteolytic cleavage and release of membrane-bound CD30 antigen
Sanchez-Madrid et al. Antigens involved in mouse cytolytic T-lymphocyte (CTL)-mediated killing: functional screening and topographic relationship
JPH01501388A (en) In vitro activation of effector cells to kill target cells
IE913959A1 (en) Antibodies that bind to a ligand-induced binding site on¹integrin and induce integrin activation
PL171920B1 (en) Method of obtaining a novel immunoglobulin polypeptide capable to inhibit pdgf-r
Matsuoka et al. A novel type of cell death of lymphocytes induced by a monoclonal antibody without participation of complement.
EP0856009A1 (en) Cd6 ligand
AU722388B2 (en) CD6 ligand
JPH09511387A (en) Novel cell surface receptor, antibody composition, and use thereof
TIMoTHY et al. Receptor Function'
Yssel et al. Distribution and functional analysis of a 120-to 130-kDa T-cell surface antigen
AU642731B2 (en) Mononuclear leukocyte directed endothelial adhesion molecule associated with atherosclerosis
Talle et al. Null cell identification and characterization with OKT16: an anti-p40 monoclonal antibody
JP2528549B2 (en) Novel monoclonal antibody that binds to human IL-2 receptor-heavy chain
Qi et al. Transformation‐associated 86 kDa natural killer target molecule expressed on the mouse, rat and human cell surface
Sanchez-Madrid MAPPING OF ANTIGENIC AND FUNCTIONAL EPITOPES ON THE a-AND/3-SUBUNITS OF TWO RELATED MOUSE GLYCOPROTEINS INVOLVED IN CELL INTERACTIONS, LFA-1 AND MAC-l
CA2137813A1 (en) Methods and compositions for inhibiting endothelial cell and fibrinogen mediated inflammation
SANCHEz-MADRID et al. Topographic Relationship
Kishimoto et al. A Novel Type of Cell Death of Lymphocytes Induced by a Monoclonal Antibody without Participation of Complement By Shuji Matsuoka,* Yoshihiro Asano,* Kunio Sano
AU2130188A (en) Peptides and antibodies that inhibit platelet adhesion
IE19960275A1 (en) Intercellular adhesion molecules, and their binding ligands